Rene Westhovens, MD, PhD - Advances in Management of Early Rheumatoid Arthritis: Where Are We Now, and Where Are We Going?
Please be sure to view the accompanying |
|
CME/CNE/CPE - Advances in Management of Early Rheumatoid Arthritis: Where Are We Now, and Where Are We Going?
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. |
|
Daniel J. Clauw, MD - Improving Patient Outcomes in Fibromyalgia Syndrome: A Clinical Update on Appropriate Diagnosis, Adequate Treatment, and Proper Management of Comorbid Conditions
This 3-part activity focuses on several aspects of the management of fibromyalgia. Highlights from the first part of the activity include the potential etiologies of fibromyalgia and tools to assist in the diagnosis of patients with this condition. The various types of pharmacologic and nonpharmacologic therapeutic approaches for fibromyalgia are discussed in the second part of the program. The third part of the activity addresses the treatment of comorbidity in patients with fibromyalgia. It also emphasizes the importance of an interdisciplinary approach for the management of fibromyalgia. |
|
CME/CNE/CPE - Improving Patient Outcomes in Fibromyalgia Syndrome: A Clinical Update on Appropriate Diagnosis, Adequate Treatment, and Proper Management of Comorbid Conditions
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. |
|
Eric M. Ruderman, MD - Defining Clinical Practice in Early Rheumatoid Arthritis: An Expert Discussion
In this activity, experts in RA discuss current evidence on optimal management of early RA, including the use of biologic agents. |
|
CME/CNE/CPE - Defining Clinical Practice in Early Rheumatoid Arthritis: An Expert Discussion
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. |
|
Paul Emery, MA, MD - Benefits of Early, Aggressive, and Appropriate Intervention in Rheumatoid Arthritis
In this activity, experts in management of rheumatoid arthritis discuss the importance of early, aggressive management of rheumatoid arthritis. |
|
CME/CNE/CPE Information - Benefits of Early, Aggressive, and Appropriate Intervention in Rheumatoid Arthritis
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. |
|
Joel M. Kremer, MD - Current Perspectives and Latest Data in Undifferentiated Inflammatory & Rheumatoid Arthritis
In this activity, experts in rheumatology discuss the latest data on treatment of RA, including the emerging evidence supporting early use of traditional and biologic antirheumatic drugs in undifferentiated arthritis and early stage RA, as well as up-to-date findings regarding the efficacy and safety of T- and B-cell-targeted biologics in RA. |
|
CME/CNE/CPE - Current Perspectives and Latest Data in Undifferentiated Inflammatory & Rheumatoid Arthritis
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. |
|
Gregg J. Silverman, MD - The State of the Science in Managing Systemic Lupus Erythematosus: Update From EULAR 2008
In this activity, experts on SLE review current and emerging treatments, discuss the latest treatment guidelines from EULAR, and propose therapeutic strategies for patients with lupus nephritis. |
|
CME/CE Information - The State of the Science in Managing Systemic Lupus Erythematosus: Update From EULAR 2008
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Philip Mease, MD - Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
In this activity, experts in the treatment of rheumatoid arthritis evaluate recent data on the impact of newer biologics on functional outcomes and quality-of-life parameters. A review of the efficacy and safety of these agents is featured.
|
|
CME/CE Information Beyond Efficacy and Safety in Rheumatoid Arthritis Treatment: Quality-of-Life Outcomes With Newer Biologics in RA
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Felicia Cosman, MD - Updates in the Diagnosis and Management of Osteoporosis: A Rheumatology Perspective
In this CME activity, an expert in the management of osteoporosis discusses optimal diagnostic approaches and recent data on strategies to manage this condition. The role of the rheumatologist in the management of osteoporosis is also reviewed. |
|
CME/CE Information - Updates in the Diagnosis and Management of Osteoporosis: A Rheumatology Perspective
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Joel M. Kremer, MD - Safety Update of Newer Biologics in Refractory Rheumatoid Arthritis
In this activity, experts in the treatment of rheumatoid arthritis |
|
CME/CE Information - Safety Update of Newer Biologics in Refractory Rheumatoid Arthritis
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Paul Emery, MD, FRCP - Long-Term Efficacy of Newer Biologics in Refractory Rheumatoid Arthritis
In this activity, experts in the treatment of rheumatoid arthritis discuss recent data on the use of abatacept and rituximab in methotrexate- or TNF-antagonist-refractory rheumatoid arthritis. |
|
CME/CE Information - Long-Term Efficacy of Newer Biologics in Refractory Rheumatoid Arthritis
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Mark Genovese, MD - Clinical Update on Biologic Treatment Options for Rheumatoid Arthritis
In this CME activity, experts provide an update on the latest data on efficacy and safety of current and novel biologic therapies for rheumatoid arthritis |
|
CME/CE Information - Clinical Update on Biologic Treatment Options for Rheumatoid Arthritis
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Daniel J. Clauw, MD - Understanding and Managing the Fibromyalgia Syndrome
In this CME activity, experts in the treatment of fibromyalgia present recent data on its diagnosis and management. Recent research on causes, mechanisms, and genetic markers are also highlighted. |
|
CME/CE Information - Understanding and Managing the Fibromyalgia Syndrome
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Michael Schiff, MD - Expanding the Options in RA: Where Do the Newer Biologics Fit?
In this activity, experts in the treatment of rheumatoid arthritis review recent data on the safety and efficacy of newer biologics for the treatment of patients with this condition. |
|
CME/CE Information - Expanding the Options in RA: Where Do the Newer Biologics Fit?
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
Stanley B. Cohen, MD - Challenges in Managing Rheumatoid Arthritis With Biologics: A Case-Based Approach
In this CME activity, an expert discusses treatment of rheumatoid arthritis based on relevant case scenarios, with a main focus on optimal use of biologic therapies in the context of other available treatment options. |
|
CME/CE Information - Challenges in Managing Rheumatoid Arthritis With Biologics: A Case-Based Approach
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. |
|
